Appendix 2

Reviewer Relationships With Industry and Other Entities (Relevant)—2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy

Peer ReviewerRepresentationConsultantSpeaker's BureauOwnership/ Partnership/ PrincipalPersonal ResearchInstitutional, Organizational, or Other Financial BenefitExpert Witness
David R. Holmes, JrOfficial Reviewer—ACCF Board of Governors/ACCF Interventional Scientific CouncilNoneNoneNoneNoneNoneNone
William J. McKennaOfficial Reviewer—AHANoneNoneNoneNoneNoneNone
William G. StevensonOfficial Reviewer—ACCF/AHA Task Force on Practice GuidelinesNoneNoneNoneNoneNoneNone
Carole A. WarnesOfficial Reviewer—ACCF Board of TrusteesNoneNoneNoneNoneNoneNone
Michael ArgenzianoOrganizational Reviewer—AATSNoneNoneNoneNoneNoneNone
Drew E. BaldwinOrganizational Reviewer—SCAINoneNoneNone
  • Atrium

  • GlaxoSmithWellcome

  • Harvard Clinical Research Institute

  • Greater New Orleans Health Services Corps

Hugh CalkinsOrganizational Reviewer—HRS
  • Medtronic

  • Boston Scientific

  • Boston Scientific

  • Medtronic

  • St. Jude Medical

Milind Y. DesaiOrganizational Reviewer—ASNCNoneNoneNoneNoneNoneNone
Vasken DilsizianOrganizational Reviewer—ASNCNoneNoneNoneNoneNoneNone
N.A. Mark Estes IIIOrganizational Reviewer—HRS
  • Boston Scientific

Michael GivertzOrganizational Reviewer—HFSANoneNoneNoneNoneNoneNone
Stuart KatzOrganizational Reviewer—HFSA
  • Amgen

  • Bristol-Myers Squibb

  • Paracor

  • Terumo

• OtsukaNoneNoneNoneNone
John A. KernOrganizational Reviewer—AATSNoneNoneNoneNoneNoneNone
Sherif NaguehOrganizational Reviewer—ASENoneNoneNoneNoneNoneNone
Paul SorajjaOrganizational Reviewer—SCAINoneNoneNoneNoneNoneNone
Kirk T. SpencerOrganizational Reviewer—ASENoneNoneNoneNoneNoneNone
Gus J. VlahakesOrganizational Reviewer—STSNoneNoneNoneNoneNoneNone
Herbert B. WardOrganizational Reviewer—STSNoneNoneNoneNoneNoneNone
Nancy M. AlbertContent Reviewer—ACCF/AHA Task Force on Practice GuidelinesNoneNoneNoneNoneNoneNone
Jeffrey L. AndersonContent Reviewer—ACCF/AHA Task Force on Practice GuidelinesNoneNoneNone
  • AstraZeneca (DSMB)

  • Toshiba

Richard G. BachContent ReviewerNoneNoneNoneNoneNoneNone
Jorge A. BelardiContent Reviewer—ACCF Interventional Scientific Council
  • Boston Scientific

  • Medtronic CardioVascular

  • Medtronic Vascular

  • Abbott

  • Boston Scientific

Eugene BraunwaldContent ReviewerNoneNoneNoneNoneNoneNone
John E. Brush, JrContent Reviewer
  • Prometheus Payment

  • United Healthcare

James A. BurkeContent Reviewer—ACCF Interventional Scientific CouncilNoneNoneNoneNoneNoneNone
Jose G. DiezContent Reviewer—ACCF Interventional Scientific Council
  • Sanofi-aventis

  • Sanofi-aventis

Jon C. GeorgeContent Reviewer—ACCF Interventional Scientific CouncilNoneNoneNoneNoneNoneNone
Robert A. GuytonContent Reviewer—ACCF/AHA Task Force on Practice GuidelinesNoneNoneNoneNoneNoneNone
Judith S. HochmanContent Reviewer—ACCF/AHA Task Force on Practice Guidelines
  • GlaxoSmithKline

Frederick G. KushnerContent Reviewer—ACCF/AHA Task Force on Practice GuidelinesNoneNoneNoneNoneNoneNone
Gilead I. LancasterContent Reviewer—ACCF Board of GovernorsNoneNone
  • Cardiogal

Bruce W. LytleContent ReviewerNoneNoneNoneNoneNoneNone
Abeel A. MangiContent ReviewerNoneNoneNoneNoneNoneNone
Gerard R. MartinContent Reviewer—ACCF Adult Congenital and Pediatric Cardiology CouncilNoneNoneNoneNoneNoneNone
Debabrata MukherjeeContent Reviewer—ACCF Interventional Scientific CouncilNoneNoneNoneNoneNoneNone
Joseph P. MurgoContent ReviewerNoneNoneNoneNoneNoneNone
Patrick T. O'GaraContent ReviewerNoneNoneNoneNoneNoneNone
E. Magnus OhmanContent Reviewer—ACCF/AHA Task Force on Practice GuidelinesNoneNoneNoneNoneNoneNone
John F. RobbContent Reviewer—ACCF Board of GovernorsNoneNoneNoneNoneNoneNone
George P. RodgersContent Reviewer—ACCF Board of GovernorsNoneNoneNoneNoneNoneNone
Chris SemsarianContent ReviewerNoneNoneNoneNoneNoneNone
Richard J. SheminContent Reviewer—ACCF Surgeons' Scientific Council
  • Edwards Lifesciences

Mark V. SherridContent ReviewerNone
  • Boston Scientific

  • GeneDx

  • Medtronic

  • St. Jude Medical

  • CardioNet

William H. SpencerContent ReviewerNoneNone
  • Medtronic

Paolo SpiritoContent ReviewerNoneNoneNoneNoneNoneNone
Edward F. TerrienContent Reviewer—ACCF Board of GovernorsNoneNoneNoneNoneNoneNone
Juan VillafaneContent Reviewer—ACCF Board of GovernorsNoneNoneNoneNoneNoneNone
Gary D. WebbContent Reviewer—ACCF Adult Congenital and Pediatric Cardiology CouncilNoneNoneNoneNoneNoneNone
Walter R. WilsonContent ReviewerNoneNoneNoneNoneNoneNone

This table represents the relationships of reviewers with industry and other entities that were disclosed at the time of peer review and determined to be relevant. It does not necessarily reflect relationships with industry at the time of publication. A person is deemed to have a significant interest in a business if the interest represents ownership of ≥5% of the voting stock or share of the business entity, or ownership of ≥$10,000 of the fair market value of the business entity; or if funds received by the person from the business entity exceed 5% of the person's gross income for the previous year. A relationship is considered to be modest if it is less than significant under the preceding definition. Relationships that exist with no financial benefit are also included for the purpose of transparency. Relationships in this table are modest unless otherwise noted. Names are listed in alphabetical order within each category of review.

AATS indicates American Association for Thoracic Surgery; ACCF, American College of Cardiology Foundation; AHA, American Heart Association; ASE, American Society of Echocardiography; ASNC, American Society of Nuclear Cardiology; DSMB, data safety monitoring board; HFSA, Heart Failure Society of America; HRS, Heart Rhythm Society; SCAI, Society for Cardiovascular Angiography and Interventions; and STS, Society of Thoracic Surgeons.

  • Significant relationship.

  • No financial benefit.